【Introduction】
Product Name: Human SLC2A8 Antibody (VB1-050, Research Use)
Catalog Number: NBR-0874
Target Name: SLC2A8
Trade Name: VB1-050
Antibody Drug Description: Anti-SLC2A8 ADCC Enhanced Antibody (VB1-050) is an ADCC enhanced antibody produced by Afuco™ platform. VB1-050 is an IgG MAb generated from pooled lymphocytes of cancer patient samples, using standard hybridoma techniques. This antibody demonstrates preferential binding to a host of tumor cell lines, including breast, liver, prostate and colon, with limited normal tissue reactivity. Further research is ongoing to assess the potential clinical exploitation of VB1-050/Glut-8.
【Description】
Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS:N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG
【Gene Information】
Gene Name: SLC2A8
Synonyms: GLUT8; GLUTX1
Target Description: Insulin-regulated facilitative hexose transporter that mediates the transport of glucose and fructose. Also able to mediate the transport of dehydroascorbate.
Ensembl: ENSG00000136856
Uniprot: Q9NY64